It’s Time For A Precision Medicine Paradigm Shift
We recently highlighted a new landmark publication from JCO Precision Oncology which explores the clinical practice gaps limiting patient access to targeted treatments. The study focused on advanced non-small cell lung cancer (aNSCLC) because this disease provides significant opportunities for the deployment of personalized medicine strategies, with 70% of patients expressing an actionable mutation potentially amenable to available targeted therapies. The […]
